Clinical Trials Browser

Phase 1 × Hydroxyurea × Other solid neoplasm × Clear all

NCT07190833 2025-09-24

A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea)

Phase 1 Not yet recruiting

Other solid neoplasm

Treatment-Refractory Solid Tumors

NCT01521299 2012-08-28

A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors

Phase 1 Withdrawn

Other solid neoplasm

Advanced Solid Tumors